Abstract
The right combination of drugs and surgical treatment can improve systolic function and prevent, attenuate, or reverse heart failure. Patient education and disease management programs can reduce hospitalizations. Optimal treatment for each patient is guided by a thorough evaluation and use of functional classification and disease staging systems.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use
-
Angiotensin-Converting Enzyme Inhibitors / administration & dosage
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
-
Carbazoles / therapeutic use
-
Cardiac Pacing, Artificial
-
Carvedilol
-
Chronic Disease
-
Female
-
Heart Failure / drug therapy*
-
Heart Failure / therapy
-
Heart-Assist Devices
-
Humans
-
Middle Aged
-
Propanolamines / therapeutic use
Substances
-
Adrenergic beta-Antagonists
-
Angiotensin-Converting Enzyme Inhibitors
-
Carbazoles
-
Propanolamines
-
Carvedilol